SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001622627-24-000035
Filing Date
2024-05-29
Accepted
2024-05-29 15:47:53
Documents
2
Group Members
AHARON GILROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.SALAMON STEVEN A J

Document Format Files

Seq Description Document Type Size
1 rosalind_kprx_13g_feb202.htm SC 13G 90667
2 rosalind_kprx_exa_may202.htm EX-99.A BD-DIR-RESOL 2333
  Complete submission text file 0001622627-24-000035.txt   94832
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88748 | Film No.: 24998094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G